Innovation Forum Events

BioCap 2018 Conference

Thursday, September 27th 2018

Add to calendar

08:30 – 16:45 (GMT)

Alderley Park Conference Centre, Alderley Park, Cheshire, SK10 4TG

View map

Do you want to attend? Get your ticket!

Register Now


Now in it's seventh year, the BioCap Conference provides a unique meeting place connecting investors, companies who are seeking finance and those who have a track record of raising finance.

BioCap is the only specialist life science investment and showcase conference in the North of England and is aimed at highlighting the wealth of life science investment opportunities.

This one day conference is a great opportunity to meet with potential partners and investors. Helping businesses to realise their full potential, whatever your funding requirements are.

Call For Pitches Competition 
As part of the conference, we will continue to host the popular 'Company Pitching' competition.  The submission of applications has now closed and the companies who will be presenting will be announced shortly.




08.30 - 09.00

Coffee & Registration


09.00 - 09.20

BioCap Investment Insights

Laurence Barker, Chief Business Officer, Dementia Discovery Funds 

09.20 - 10.05

Angel Track: SEIS and EIS Investment Opportunities

Savvas Neophytou, Head of Life Sciences, Deepbridge Capital
Katerina Sanchez-Schilling, Investment Analyst, Syndicate Room

Company Presentations
Sam Whitehouse, CEO, Lightox
Marcus Orton, CEO, SwabTech
Richard Mills, CEO SleepCogni

10.05 - 10.25

BioCap Investment Insights

Hamish Graham, Pfizer Healthcare Hub: London Manager

10.25 - 11.10

Tech & Digital Track: What's hot in the digital area?

Volker Hirsch, Angel Investor

Company Presentations
Shameem Sampath, Founder, Knee Tracker
Rory Cameron, Chief Operating Officer, Gendius
Daniel Jamieson, CEO / Founder, Biorelate

11.10 - 11.40

Coffee, Networking & Exhibition


11.40 - 13.10

Company Pitching Competition

Sponsored by Catapult Ventures

Head Judge:
Gareth King, Life Science Partner, Catapult Ventures

Claire Brown, Investment Director, BioCity
Mark Wyatt, Investment Director, Mercia Technologies
Rebecca Todd, Investment Director, Longwall Ventures

13.10 - 14.10

Lunch, Networking & Exhibition


14.10 - 14.30

BioCap Investment Insight

David Porter, Managing Partner, Apposite Capital

14.30 - 14.50

BioCap Investment Insight

To be confirmed

14.50 - 15.55

Start-up / Pre-Start Zone

Pharmnovo -  Liverpool John Moores University
Next Generation OCT Device - University of Liverpool

15.55 - 16.15

Chinese Capital & Markets - What's the Opportunity

Simon Haworth, CEO, Dynasty Biotechnology

16.15 - 16.35

BioCap Investment Insight

Kath MacKay, Interim Director Ageing Society, Health & Nutrition, Innovate UK

16.35 - 16.45

Results of Pitching Competition

Gareth King, Life Science Partner, Catapult Ventures




We have previously attracted some of the leading life science investors organisations to BioCap including (but not limited to):
Acceleris Capital, Advent Venture Partners, Albion Ventures, Alderley Park Ventures, Amadeus Capital Partners, Amgen, Angel Capital Group, Astellas, AstraZeneca, Bamburgh Capital, Brightstar Partners, Cantor Fitzgerald, Capital Enterprise, Capital Cell, Catapult Ventures, Deepbridge Capital, Diagnostic Capital, Epiphany Capital, Edmond De Rothschild Investment Partners, Enterprise Ventures, Epidarex Capital, EV Group, Foresight Group, Fund, FreeMind Group, Fullbrook Thorpe, Finance Wales, Finance Yorkshire, GM&C Life Sciences, Ignite Capital Partners, Imperial Innovations, InnovateUK, IP Group, Johnson & Johnson Innovation, Kreos Capital, Laidlaw & Company, Liberum, Life Science Biznes Consulting, Longbow Capital, London Stock Exchange, Ludlow Wealth Management, Maven, Medius Associates, Merck Sharpe & Dohme, Mercia Fund Management, Midven, MVM Life Science Partners, Nasdaq, Net Scientific, New Wave Ventures, Northstar Ventures, North West Business Angels, Panmure Gordon, Parkwalk Advisors, Peel Hunt, Pfizer LLC, RBS,Results Healthcare, Scottish Equity Partners, Seroba, Seymour Pierce, Shore Capital, Sixth Element Capital, Spark Impact Ltd, SV Life Sciences, Syncona Investment Management,Syndicate Room, Synergy Health, Tbailey, Takeda Ventures, Takeda TAKcelerator, Torreya Partners, Touchstone Innovations, UKTI VC Unit, Ventac Partners, Wellcome Trust, Wales Business Angels, Warwick Ventures, West Coast Business Angels, Wellcome Trust, WG Partners, Warwick Ventures, WGN, Xenos, Zeus Capital, YFM with more to follow....

Delegate Fees
Premium Member: £125.00 + VAT 
Member: £155.00 + VAT 
Non-Member: £250.00 + VAT

Investor Dinner
Delegates who have registered for the BioCap Conference also have the opportunity to attend the Investor Dinner which is taking place on the evening of Wednesday 26th September at Mereside Restaurant, Alderley. There will be an additional cost of £50.00 + VAT per person and you can register your place by contacting Helen Williams at [email protected]*. 
*Please note that delegate places at the Investor Dinner are strictly limited.

We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.